Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.554
Peer-review started: March 26, 2023
First decision: May 25, 2023
Revised: June 6, 2023
Accepted: June 16, 2023
Article in press: June 16, 2023
Published online: July 18, 2023
Processing time: 113 Days and 18.1 Hours
There is no data on the clinical outcomes of patients older than 70 admitted with open ankle fractures. This study sets the foundation for future research trials in elderly population.
This is the only study looking at patients older than 70 with open ankle fractures. This study highlights the multiple factors which can predict the poor outcome in this age group with open ankle fractures. There is no consensus on the best management strategy for these injuries in this population.
The overall objective of this study is to look at the predictors of poor clinical outcome in patients older than 70 with open ankle fractures.
This is a retrospective observational study performed on 22 years of prospectively collated data from an electronic database in a district general hospital. We used R 4.2.2 (R foundation) to perform statistical analysis.
We identified 37 patients above 70 years of age admitted over the period of 22 years with an open ankle fractures. Sixteen patients developed deep surgical site infections, with 4 requiring multiple wash outs. Eight patients developed superficial surgical site infections and were managed with antibiotics and regular dressing change. The 10 years mortality rate in this age group was 57%. The presence of a cardiac and stroke history, cancer, or prolonged inpatient stay were found to be the predictors of mortality.
We concluded that there is a 20% risk of patients above 70 years of age with open ankle fracture requiring repeated surgical intervention. The need for repeated surgical interventions is mainly due to deep Surgical Site Infections. We identified multiple predictors for worse outcome. However, the presence of a cardiac history appears to be the main predictor for wound complications.
This study sets the foundation for further research trials in patients above 70 years of age.
